Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Methylome-driven regulation of miRNA expression and its relationship to cardiac dysfunction in idiopathic dilated cardiomyopathy

  • Delgado-Arija, Marta
  • Gallego-Martínez, Alex
  • González-Torrent, Irene
  • Pérez-Carrillo, Lorena
  • Benedicto-Marrero, Carlota
  • Juan Bodí-Miret
  • Portolés, Manuel
  • Roselló-Lletí, Esther
  • Tarazón, Estefanía
[EN] Background Idiopathic dilated cardiomyopathy (iDCM) is a multifactorial disease with a complex pathogenesis involving diverse molecular mechanisms. Among these, epigenetic mechanisms, including both DNA methylation and microRNAs (miRNAs)-mediated regulation, play an important role in determining the disease phenotype. However, the interplay between the DNA methylome and the miRNA transcriptome in iDCM remains largely unexplored. Methods We conducted a cross-cohort multiomic integrative analysis of left ventricular (LV) tissue samples from iDCM patients and control (CNT) donors. DNA methylation profiling was performed using the Infinium MethylationEPIC BeadChip, whereas ncRNA-seq was used to assess transcriptomic changes. Results We identified a subset of three miRNAs exhibiting both differential methylation in their promoter regions and differential expression in their primary and mature forms. Notably, the miRNA hsa-miR-433-3p (r¿=¿0.671, p¿<¿0.01), which is involved in fibrotic pathways, appear to be significantly correlated with the left ventricular ejection fraction (LVEF), an established echocardiographic marker of cardiac function. Conclusions This study enhances our understanding of the epigenetic mechanisms shaping the miRNA transcriptomic landscape in iDCM, suggesting potential roles for these miRNAs in cardiac dysfunction and myocardial fibrosis., This work was supported by the National Institute of Health Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III (Projects: PI20/00071, PI24/00088, PI24/01310) co-funded by European Union; Miguel Servet contract: CP21/00041 co-funded by European Union; contract FI21/00186]; Consorcio Centro de Investigación Biomédica en Red [CIBERCV, under Grant CB16/11/00261]; Ministry of Science and Innovation (MCIN,https://doi. org/10.13039/501100011033) and State Investigation Agency (AEI) (Project CNS2022-135769 and CNS2024-1544396) co-funded by European Union NextGeneration EU and the European Recovery, Transformation and Resilience Plan (PRTR); Conselleria de Educación, Universidades y Empleo (Project CIA&#8209;ICO/2022/246, contract CIACIF/2022/429).